Although a series of studies have shown that STAT3 is an ideal target for cancer therapy, at present, effective therapeutic interventions to inhibit STAT3 and produce powerful anti-tumor effects in the clinical environment need to be further explored and developed [14]. The gene discussed is STAT3; the disease is cancer.